Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2004-12-17
2008-12-02
Landsman, Robert (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S350000, C530S300000
Reexamination Certificate
active
07459533
ABSTRACT:
Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
REFERENCES:
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5536637 (1996-07-01), Jacobs
patent: 6274710 (2001-08-01), Dumoutier et al.
patent: 6331613 (2001-12-01), Dumoutier et al.
patent: 6359117 (2002-03-01), Dumoutier et al.
patent: 6551799 (2003-04-01), Gurney et al.
patent: 2001/0024652 (2001-09-01), Dumoutier et al.
patent: 2002/0012669 (2002-01-01), Presnell et al.
patent: 2002/0102723 (2002-08-01), Gurney et al.
patent: 2002/0187523 (2002-12-01), Tang et al.
patent: 2003/0012788 (2003-01-01), Renauld et al.
patent: 2003/0170823 (2003-09-01), Presnell et al.
patent: 2004/0023341 (2004-02-01), Xu et al.
patent: 2004/0110189 (2004-06-01), Dumoutier et al.
patent: 2004/0152125 (2004-08-01), Presnell et al.
patent: 2004/0180399 (2004-09-01), Renauld et al.
patent: WO 94/01548 (1994-01-01), None
patent: WO 99/61617 (1999-12-01), None
patent: WO 00/24758 (2000-05-01), None
patent: WO 00/70049 (2000-11-01), None
patent: WO 00/73457 (2000-12-01), None
patent: WO 00/77037 (2000-12-01), None
patent: WO 01/46422 (2001-06-01), None
patent: WO 02/10393 (2002-02-01), None
patent: WO02/16611 (2002-02-01), None
Amelizad Z et al. Accession No. A60822, Biochem. Pharmacol. 37, 3245-3249, 1988.
Skolnick et al. Trends in Biotech. 18:34-39, 2000.
Bork P. Genome Research 10:398-400, 2000.
Doerks et al. Trends in Genetics 14:248-250, 1998.
Smith et al. Nature Biotechnology 15:1222-1223, 1997.
Brenner SE. Trends in Genetics 15:132-133, 1999.
Bork, et al. Trends in Genetics 12:425-427, 1996.
R&D Systems, Catalog NR, AF582, XP002307633, “Anti-Mouse IL-22 Antibody,” Aug. 22, 2002.
Kotenko, Sergei, “The Family of IL-10-Related Cytokines and Receptors: Related, But to What Extent?”, Cytokine and Growth Factor Reviews, 13(3):223-240, Jun. 2002.
Radaeva, Svetlana, et al., “Interleukin 22 (IL-22) Plays a Protective Role in T Cell-Mediated Murine Hepatitis: IL-22 is a Survival Factor for Hepatocytes via STAT3 Activation,” Hepatology, 39(5):1332-1342, May 2004.
Resmini, Christine, et al., “An Anti-Murine IL-22 Monoclonal Antibody Decreases Disease Severity in a Murine Model of Collagen Induced Arthritis,” European Cytokine Network, 14(Supplement 3):129, Sep. 2003, and Annual Meeting of the International Cytokine Society; Dublin, Ireland, ISSN: 1148-5493, Sep. 20-24, 2003.
Li, J., et al., “Temporal Associations Between Interleukin 22 and the Extracellular Domains of IL-22R and IL-10R2,” International Immunopharmacology, Elsevier, Amsterdam, NL, 4(5):693-708, May 2004.
Waterston, R., et al., GenBank Accession No. AC006734 forCaenorhabditis elegansclone 434B4, Feb. 25, 1999.
Wilson, R., et al., J. Mol. Biol., 261:155-172, 1996.
Bork et al., Trends in Genetics, 12:425-427, 1996.
Dumoutier et al., “Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9,” J. of Immunol., 164:1814-1819, 2000.
Syrbe et al., Springer Seminars in Immunopathology, 21:263-285, 1999.
Aoki, I., et al., “Comparison of the amino acid and nucleotide sequences between human and two guinea pig major basic proteins,” FEBS Lett., 282(1):56-60, 1991.
Dumoutier, L., et al., “Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor,” Proceedings of the National Academy of Sciences of USA, 97(18):10144-10149, 2000.
Dumoutier, L., et al., “IL-TIF/IL-21: genomic organization and mapping of the human and mouse genes,” Genes Immun., 1:488-494, 2000.
Dumoutier, L., et al., GenBank Accession No. NM—016971 forMus musculusinterleukin 10-related T cell-derived inducible factor (IItif), Jun. 8, 2000.
Ozaki, T., et al., GenBank Accession No. D13973 forDictyostelium discoideumDNA for Dp87 protein, Feb. 1, 2000.
Aoki, I., et al., GenBank Accession No. P35709 forEosinophil granulemajor basic protein 2 precursor (mbp-2), May 30, 2000.
Mahairas, G. G., et al., GenBank Accession No. AQ104025 for HS—3108—B1—C01—T7 CIT Approved Human Genomic Sperm Library DHomo spaiensgenomic clone Plate=3108 Col=1 Row=F, Aug. 28, 1998.
Xie, M., et al., GenBank Accession No. AF279437 forHomo sapiensinterleukin 22 (IL22), Oct. 9, 2000.
Dumoutier, L., et al., GenBank Accession No. AJ294727 forMus musculusILTIFa gene for IL TIF alpha protein (IL-22), exons 1a-5, Dec. 21, 2000.
Dumoutier, L., et al., GenBank Accession No. NP—065386 for Interleukin 22; Interleukin 21; IL-10-related T-cell-derived inducible factor (Homo sapiens), Nov. 2, 2000.
Ozaki, T., et al., “Developmental regulation of transcription of a novel prespore-specific gene (Dp87) inDictyostelium discoideum,” Development, 1.17(4):1299-1308, 1993.
Sambrook, J., et al., Molecular Cloning. A laboratory manual, 2nded., Cold Spring Harbor Laboratory Press, Ch. 17, 1989.
Xie, M. H., et al., “Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R,” J. of Biol. Chem., 275(40):31335-31339, 2000.
Kotenko, Sergei V., et al., “Identification of the functional Interleukin-22 (IL-22) receptor complex. The IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes,” J. Biol. Chem., 276(4):2725-2732, 2001.
Dumoutier, L., et al., “IL-TIF induces acute phase reactant production by hepatocytes through IL-10Rbeta,” Immunology Letters, 73(2-3):261, 2000.
Lambert, A., et al., “Novel cytokine IL-22 administrated by adenovirus vector or as recombinant purified protein induces acute-phase responses and renal tubular basophilia in female C57BL/6 mice,” Toxicologic Pathology, 29:6:712, 2001.
Mahairas et al., PNAS USA, 96(17):9739-9744, 1999.
Vukicevic et al., PNAS USA, 93:9021-9026, 1996.
Massague, J. Cell., 49:437-438, 1987.
Pilbeam et al., Bone, 14:717-720, 1993.
Fouser Lynette
Jacobs Kenneth
Spaulding Vikki
Xuan Dejun
Finnegan Henderson Farabow Garrett & Dunner, LLP.
Genetics Institute, LLC.
Landsman Robert
LandOfFree
Human GIL-19/AE289 proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human GIL-19/AE289 proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human GIL-19/AE289 proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4040136